Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 3, 2012, Pages 638-649

  Thomsen, Alex Rojas Bie ^a,b   Worm, Jesper ^b   Jacobsen, Stine Engesgaard ^a   Stahlhut, Martin ^b   Latta, Markus ^b   Braüner Osborne, Hans ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM ION; CALCIUM SENSING RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STRONTIUM;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CANCER CELL CULTURE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORMONE RELEASE; INHIBITION KINETICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THYROID CARCINOMA; THYROID PARAFOLLICULAR CELL;

ANIMALS; CALCITONIN; CALCIUM; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; RATS; RECEPTORS, CALCIUM-SENSING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRONTIUM; THYROID NEOPLASMS;

EID: 84869208873     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.197210     Document Type: Article

References (67)

1. Akella R, Moon TM, and Goldsmith EJ (2008) Unique MAP kinase binding sites. Biochim Biophys Acta 1784:48-55.
2. Almadén Y, Canalejo A, Ballesteros E, Añón G, Cañadillas S, and Rodríguez M (2002) Regulation of arachidonic acid production by intracellular calcium in parathyroid cells: effect of extracellular phosphate. J Am Soc Nephrol 13:693-698.
3. Awata H, Huang C, Handlogten ME, and Miller RT (2001) Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276:34871-34879.
4. Bai D, del Corsso C, Srinivas M, and Spray DC (2006) Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB). J Pharmacol Exp Ther 319:1452-1458.
5. 2+ inflow. Biochem Pharmacol 49:1373-1379.
6. Bouschet T, Martin S, Kanamarlapudi V, Mundell S, and Henley JM (2007) The calcium-sensing receptor changes cell shape via a β-arrestin-1 ARNO ARF6 ELMO protein network. J Cell Sci 120:2489-2497. (Pubitemid 47323858)
7. Brennan TC, Rybchyn MS, Green W, Atwa S, Conigrave AD, and Mason RS (2009) Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol 157:1291-1300.
8. 2+-sensing receptor from bovine parathyroid. Nature 366:575-580.
9. Caudrillier A, Hurtel-Lemaire AS, Wattel A, Cournarie F, Godin C, Petit L, Petit JP, Terwilliger E, Kamel S, Brown EM, et al. (2010) Strontium ranelate decreases receptor activator of nuclear factor-κB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor. Mol Pharmacol 78:569-576.
10. Chakravarti B, Chattopadhyay N, and Brown EM (2012) Signaling through the extracellular calcium-sensing receptor (CaSR). Adv Exp Med Biol 740:103-142.
11. Chang W, Tu C, Chen TH, Bikle D, and Shoback D (2008) The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1:ra1.
12. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, and Brown EM (2007) The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 74:438-447. (Pubitemid 46970843)
13. Chonchol M, Locatelli F, Abboud HE, Charytan C, de Francisco AL, Jolly S, Kaplan M, Roger SD, Sarkar S, Albizem MB, et al. (2009) A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Am J Kidney Dis 53:197-207.
14. Cidon S, Tamir H, Nunez EA, and Gershon MD (1991) ATP-dependent uptake of 5-hydroxytryptamine by secretory granules isolated from thyroid parafollicular cells. J Biol Chem 266:4392-4400. (Pubitemid 21909369)
15. Conigrave AD, Mun HC, and Lok HC (2007) Aromatic L-amino acids activate the calcium-sensing receptor. J Nutr 137:1524S-1527S; discussion 1548S.
16. Coulombe J, Faure H, Robin B, and Ruat M (2004) In vitro effects ofstrontium ranelate on the extracellular calcium-sensing receptor. Biochem Biophys Res Commun 323:1184-1190. (Pubitemid 39296549)
17. Davey AE, Leach K, Valant C, Conigrave AD, Sexton PM, and Christopoulos A (2012) Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor. Endocrinology 153:1232-1241.
18. 2-adrenergic receptor. J Biol Chem 283:5669-5676.
19. Farooqui AA and Horrocks LA (2005) Signaling and interplay mediated by phospholipases A2, C, and D in LA-N-1 cell nuclei. Reprod Nutr Dev 45:613-631. (Pubitemid 41511885)
20. Fromigué O, Haÿ E, Barbara A, Petrel C, Traiffort E, Ruat M, and Marie PJ (2009) Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate. J Cell Mol Med 13:2189-2199.
21. Henley C 3rd, Yang Y, Davis J, Lu JY, Morony S, Fan W, Florio M, Sun B, Shatzen E, Pretorius JK, et al. (2011) Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion. J Pharmacol Exp Ther 337:681-691.
22. Hjälm G, MacLeod RJ, Kifor O, Chattopadhyay N, and Brown EM (2001) Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 276:34880-34887.
23. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, and Seidman CE (1995) A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389-394.
24. 2+ channels in rabbit colonic smooth muscle cells by c-Src and focal adhesion kinase. J Biol Chem 273:5337-5342.
25. 12/13 to activate phospholipase D in Madin-Darby canine kidney cells. Am J Physiol Cell Physiol 286:C22-C230.
26. Kantham L, Quinn SJ, Egbuna OI, Baxi K, Butters R, Pang JL, Pollak MR, Goltzman D, and Brown EM (2009) The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. Am J Physiol Endocrinol Metab 297:E915-E923.
27. Kenakin T (2011) Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther 336:296-302.
28. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, and Brown EM (2001) Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280:F291-F302.
29. Lagaud GJ, Lam E, Lui A, van Breemen C, and Laher I (1999) Nonspecific inhibition of myogenic tone by PD98059, a MEK1 inhibitor, in rat middle cerebral arteries. Biochem Biophys Res Commun 257:523-527. (Pubitemid 29301475)
30. Li RW, Yang C, Sit AS, Lin SY, Ho EY, and Leung GP (2012) Physiological and pharmacological roles of vascular nucleoside transporters. J Cardiovasc Pharmacol 59:10-15.
31. 19F-NMR. Science 335:1106-1110.
32. 2+-evoked serotonin secretion by parafollicular cells: roles in signal transduction of phosphatidylinositol 3′-kinase, and the γ and ζ isoforms of protein kinase C. J Neurosci 20:1365-1373.
33. Liu KP, Russo AF, Hsiung SC, Adlersberg M, Franke TF, Gershon MD, and Tamir H (2003) Calcium receptor-induced serotonin secretion by parafollicular cells: role of phosphatidylinositol 3-kinase-dependent signal transduction pathways. J Neurosci 23:2049-2057. (Pubitemid 36368892)
34. Makita N, Sato J, Manaka K, Shoji Y, Oishi A, Hashimoto M, Fujita T, and Iiri T (2007) An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations. Proc Natl Acad Sci U S A 104:5443-5448. (Pubitemid 47175699)
35. Mamillapalli R, VanHouten J, Zawalich W, and Wysolmerski J (2008) Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells. J Biol Chem 283:24435-24447.
36. i/o protein-dependent and -independent actions of pertussis toxin (PTX). Toxins (Basel) 3:884-899.
37. Maruyama T, Kanaji T, Nakade S, Kanno T, and Mikoshiba K (1997) 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. J Biochem 122:498-505. (Pubitemid 27443223)
38. 2+ receptor-stimulated hormone release from sheep thyroid parafollicular cells. J Physiol 502:31-44.
39. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, et al. (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-468. (Pubitemid 38133766)
40. Milhas D, Andrieu-Abadie N, Levade T, Benoist H, and Ségui B (2012) The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytes. Int J Mol Sci 13:8834-8852.
41. Mollinedo F, Gajate C, Martín-Santamaría S, and Gago F (2004) ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Curr Med Chem 11:3163-3184. (Pubitemid 39539180)
42. Nemeth EF, Heaton WH, Miller M, Fox J, Balandrin MF, Van Wagenen BC, Colloton M, Karbon W, Scherrer J, Shatzen E, et al. (2004) Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl. J Pharmacol Exp Ther 308:627-635. (Pubitemid 38134225)
43. Ortiz-Capisano MC, Ortiz PA, Garvin JL, Harding P, and Beierwaltes WH (2007a) Expression and function of the calcium-sensing receptor in juxtaglomerular cells. Hypertension 50:737-743. (Pubitemid 47442739)
44. Ortiz-Capisano MC, Ortiz PA, Harding P, Garvin JL, and Beierwaltes WH (2007b) Adenylyl cyclase isoform V mediates renin release from juxtaglomerular cells. Hypertension 49:618-624.
45. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303.
46. Powis G, Seewald MJ, Gratas C, Melder D, Riebow J, and Modest EJ (1992) Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 52:2835-2840.
47. Pulcinelli FM, Gresele P, Bonuglia M, and Gazzaniga PP (1998) Evidence for separate effects of U73122 on phospholipase C and calcium channels in human platelets. Biochem Pharmacol 56:1481-1484. (Pubitemid 28529425)
48. 2+-sensing receptor: a target for polyamines. Am J Physiol Cell Physiol 273:C1315-C1323.
49. Rajagopal S, Rajagopal K, and Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9:373-386.
50. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, and Hebert SC (1995) Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci U S A 92:131-135.
51. 2+-sensing receptor. J Biol Chem 271:5972-5975.
52. Sanz JM, Chiozzi P, Colaianna M, Zotti M, Ferrari D, Trabace L, Zuliani G, and Di Virgilio F (2012) Nimodipine inhibits amyloid β-stimulated IL-1β release from microglia. Br J Pharmacol http://dx.doi.org/10.1111/j. 1476-5381.2012.02112.x.
53. Saoudi Y, Rousseau B, Doussière J, Charrasse S, Gauthier-Rouvière C, Morin N, Sautet-Laugier C, Denarier E, Scaïfe R, Mioskowski C, et al. (2004) Calcium-independent cytoskeleton disassembly induced by BAPTA. Eur J Biochem 271:3255-3264. (Pubitemid 38998694)
54. Smajilovic S, Hansen JL, Christoffersen TE, Lewin E, Sheikh SP, Terwilliger EF, Brown EM, Haunso S, and Tfelt-Hansen J (2006) Extracellular calcium sensing in rat aortic vascular smooth muscle cells. Biochem Biophys Res Commun 348:1215-1223. (Pubitemid 44308418)
55. Smallridge RC, Kiang JG, Gist ID, Fein HG, and Galloway RJ (1992) U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells. Endocrinology 131:1883-1888.
56. Stein RC (2001) Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr Relat Cancer 8:237-248.
57. Tamir H, Liu KP, Adlersberg M, Hsiung SC, and Gershon MD (1996) Acidification of serotonin-containing secretory vesicles induced by a plasma membrane calcium receptor. J Biol Chem 271:6441-6450. (Pubitemid 26095457)
58. Tamir H, Liu KP, Hsiung SC, Adlersberg M, Nunez EA, and Gershon MD (1990) Multiple signal transduction mechanisms leading to the secretion of 5-hydroxytryptamine by MTC cells, a neurectodermally derived cell line. J Neurosci 10:3743-3753.
59. Tamir H, Piscopo I, Liu KP, Hsiung SC, Adlersberg M, Nicolaides M, al-Awqati Q, Nunez EA, and Gershon MD (1994) Secretogogue-induced gating of chloride channels in the secretory vesicles of parafollicular cells. Endocrinology 135:2045-2057. (Pubitemid 24363901)
60. Thomsen AR, Hvidtfeldt M, and Bräuner-Osborne H (2012) Biased agonism of the calcium-sensing receptor. Cell Calcium 51:107-116.
61. Torres PU (2006) Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease. J Ren Nutr 16:253-258.
62. Tsien RY (1980) New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 19:2396-2404.
63. 2+-regulated membrane fusion by synaptotagmin and SNAREs. Science 304:435-438.
64. 1 receptor-mediated signal transduction events in Chinese hamster ovary cells. Biochem Pharmacol 56:1455-1462.
65. Ward DT, McLarnon SJ, and Riccardi D (2002) Aminoglycosides increase intracellular calcium levels and ERK activity in proximal tubular OK cells expressing the extracellular calcium-sensing receptor. J Am Soc Nephrol 13:1481-1489. (Pubitemid 34579237)
66. Wie MB, Koh JY, Won MH, Lee JC, Shin TK, Moon CJ, Ha HJ, Park SM, and Kim HC (2001) BAPTA/AM, an intracellular calcium chelator, induces delayed necrosis by lipoxygenase-mediated free radicals in mouse cortical cultures. Prog Neuropsychopharmacol Biol Psychiatry 25:1641-1659. (Pubitemid 33042703)
67. Zink A, Scherübl H, Kliemann D, Höflich M, Ziegler R, and Raue F (1992) Inhibitory effect of somatostatin on cAMP accumulation and calcitonin secretion in C-cells: involvement of pertussis toxin-sensitive G-proteins. Mol Cell Endocrinol 86:213-219.